<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | McKinley Blum | Activity</title>
	<link>https://www.catswannabecats.com/members/endstick15/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/endstick15/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for McKinley Blum.</description>
	<lastBuildDate>Mon, 06 Jul 2026 08:03:58 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">79c7355847159f2562feeda231a26bec</guid>
				<title>McKinley Blum posted an update: Our findings describe a role for HP1BP3 in promoting tumor [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/8175/</link>
				<pubDate>Sat, 31 May 2025 20:48:28 -0400</pubDate>

									<content:encoded><![CDATA[<p>Our findings describe a role for HP1BP3 in promoting tumor growth and metastasis by upregulating miR-23a to target TRAF5 in esophageal cancer. This study provides novel insights into the potential of targeting miRNAs for therapy and as clinical markers for cancer progression.Acute myeloid leukemia (AML) is a highly heterogenous and aggressive&hellip;<span class="activity-read-more" id="activity-read-more-8175"><a href="https://www.catswannabecats.com/activity/p/8175/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">31a7a5d1f96d67286945d22663d56016</guid>
				<title>McKinley Blum became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/8003/</link>
				<pubDate>Sat, 31 May 2025 20:30:55 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>